Aurobindo Pharma Ltd (ARBN.NS)
Fri, Dec 16 2016
MUMBAI Indian drugmaker Aurobindo Pharma Ltd's shares hit their lowest in more than nine months on Friday after the company was named in a lawsuit alleging it colluded with other drugmakers to fix prices of two commonly used drugs in the United States.
* Aurobindo Pharma Ltd says Arrow Generiques to acquire select assets in France from Teva
* Sept quarter consol net profit 6.06 billion rupees Source text for Eikon: http://bit.ly/2fS1r1x Further company coverage: (Reporting by Promit Mukherjee)
MUMBAI, Oct 6 The founders of India's Aurobindo Pharma are selling shares worth up to $135 million in a block trade on Friday, according to a deal term sheet seen by Reuters.
* Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the PEPFAR market Source text: (http://bit.ly/2cTnfIs) Further company coverage: (Bengaluru newsroom)
Aug 24 Indian shares closed slightly higher on Wednesday, led by drug maker Aurobindo Pharma Ltd after stellar quarterly results, but sentiment remained edgy as investors awaited further cues on whether the U.S. Federal Reserve will raise interest rates this year.
Aug 24 Indian shares crept up on Wednesday, led by drug maker Aurobindo Pharma Ltd after stellar quarterly results, but sentiment remained edgy as investors awaited further clues on whether the Federal Reserve will raise U.S. interest rates this year.